mylan
FDA Approves Fulphila, First Biosimilar to Neulasta
Mylan's Fulphila is the first biosimilar to Neulasta to decrease the chance of infection as suggested by febrile ...
JUNE 4, 2018
FDA Approves Simfi Triple Combo HIV Therapy
A new triple combo therapy will be available in the United States that Mylan says will be priced lower than other ...
MARCH 30, 2018
Mylan’s HIV Combo Received Tentative Approval Under FDA’s PEPFAR Program
Under PEPFAR, Mylan's HIV combination of dolutegravir, emtricitabine and tenofovir was approved.
FEBRUARY 21, 2018
Mylan’s New TLD HIV Drug Approved Under PEPFAR
TLD, an antiretroviral fixed-dose combination, will be available in developing countries as a first-line ART for ...
AUGUST 8, 2017
FDA Approves Mylan's New HIV Combo
TLE400, an antiretroviral fixed-dose combination approved under the U.S. President’s Emergency Plan for AIDS ...
MARCH 22, 2017
